GB9414157D0 - Medical use - Google Patents

Medical use

Info

Publication number
GB9414157D0
GB9414157D0 GB9414157A GB9414157A GB9414157D0 GB 9414157 D0 GB9414157 D0 GB 9414157D0 GB 9414157 A GB9414157 A GB 9414157A GB 9414157 A GB9414157 A GB 9414157A GB 9414157 D0 GB9414157 D0 GB 9414157D0
Authority
GB
United Kingdom
Prior art keywords
medical use
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB9414157A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB9414157A priority Critical patent/GB9414157D0/en
Publication of GB9414157D0 publication Critical patent/GB9414157D0/en
Priority to PCT/EP1995/002693 priority patent/WO1996002240A2/en
Priority to JP8504670A priority patent/JPH10502656A/en
Priority to EP95943503A priority patent/EP0769939A1/en
Priority to US10/038,331 priority patent/US20020082200A1/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB9414157A 1994-07-13 1994-07-13 Medical use Pending GB9414157D0 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
GB9414157A GB9414157D0 (en) 1994-07-13 1994-07-13 Medical use
PCT/EP1995/002693 WO1996002240A2 (en) 1994-07-13 1995-07-07 Use of inhibitors of human s-cd23
JP8504670A JPH10502656A (en) 1994-07-13 1995-07-07 Use of inhibitors of human S-CD23
EP95943503A EP0769939A1 (en) 1994-07-13 1995-07-07 Use of inhibitors of human s-cd23
US10/038,331 US20020082200A1 (en) 1994-07-13 2002-01-03 Use of inhibitors of human S-CD23

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9414157A GB9414157D0 (en) 1994-07-13 1994-07-13 Medical use

Publications (1)

Publication Number Publication Date
GB9414157D0 true GB9414157D0 (en) 1994-08-31

Family

ID=10758281

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9414157A Pending GB9414157D0 (en) 1994-07-13 1994-07-13 Medical use

Country Status (4)

Country Link
EP (1) EP0769939A1 (en)
JP (1) JPH10502656A (en)
GB (1) GB9414157D0 (en)
WO (1) WO1996002240A2 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601042D0 (en) * 1996-01-17 1996-03-20 Smithkline Beecham Plc Medical use
US6548084B2 (en) 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
GB9609794D0 (en) 1996-05-10 1996-07-17 Smithkline Beecham Plc Novel compounds
GB9609795D0 (en) * 1996-05-10 1996-07-17 Smithkline Beecham Plc Novel compounds
GB9706255D0 (en) 1997-03-26 1997-05-14 Smithkline Beecham Plc Novel compounds
GB9813451D0 (en) 1998-06-22 1998-08-19 Smithkline Beecham Plc Novel compounds
AU4653199A (en) * 1998-07-17 2000-02-07 Daiichi Fine Chemical Co., Ltd. Novel remedies for allergic diseases
WO2000003734A1 (en) * 1998-07-17 2000-01-27 Fuji Yakuhin Kogyo Kabushiki Kaisha Therapeutic agents for allergic diseases
GB9929527D0 (en) * 1999-12-14 2000-02-09 Smithkline Beecham Plc Novel compounds
GB9930754D0 (en) * 1999-12-29 2000-02-16 Smithkline Beecham Plc Novel compounds
US20030134880A1 (en) * 2000-02-24 2003-07-17 Gordon Bruton Novel cd23 inhibitors
EP1142910A1 (en) * 2000-04-07 2001-10-10 Jürgen Prof. Dr. Frey Inhibitors for the formation of soluble human CD23

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8827308D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
GB8827305D0 (en) * 1988-11-23 1988-12-29 British Bio Technology Compounds
ATE219776T1 (en) * 1989-03-21 2002-07-15 Us Secretary United States Dep MATRIC METALLOPROTEINASE INHIBITOR PEPTIDES
GB9001625D0 (en) * 1990-01-24 1990-03-21 Ciba Geigy Ag A pharmaceutical preparation for maturation of prothymocytes
CA2090407A1 (en) * 1990-09-21 1992-03-22 Ronald M. Evans Functional antagonism between proto-oncoprotein c-jun and hormone receptors
JPH06506202A (en) * 1991-03-22 1994-07-14 ゼノバ　リミテッド Pharmaceutical xanthone derivatives
KR930002833A (en) * 1991-07-08 1993-02-23 강석재 Device for checking break of electric circuit
GB2280439B (en) * 1992-03-11 1995-11-22 Xenova Ltd CD4 binding agents and inhibitors of collagenase and protein kinase C
AU3899193A (en) * 1992-04-07 1993-11-08 British Bio-Technology Limited Hydroxamic acid based collagenase and cytokine inhibitors
GB9223904D0 (en) * 1992-11-13 1993-01-06 British Bio Technology Inhibition of cytokine production
US5652262A (en) * 1993-03-16 1997-07-29 British Biotech Pharmaceutical, Ltd. Hydroxamic acid derivatives as metalloproteinase inhibitors
GB9307956D0 (en) * 1993-04-17 1993-06-02 Walls Alan J Hydroxamic acid derivatives
GB9320660D0 (en) * 1993-10-07 1993-11-24 British Bio Technology Inhibition of cytokine production
GB9323165D0 (en) * 1993-11-10 1994-01-05 Chiros Ltd Compounds
DE69515702T2 (en) * 1994-01-20 2000-08-10 British Biotech Pharm L-tertiary leucine-2-pyridylamide
GB9401129D0 (en) * 1994-01-21 1994-03-16 British Bio Technology Hydroxamic acid derivatives as metalloproteinase inhibitors
HUT74511A (en) * 1994-01-22 1997-01-28 British Biotech Pharm Metalloproteinase inhibitors, pharmaceutical compns. contg. them and process to prepare the said compds.

Also Published As

Publication number Publication date
EP0769939A1 (en) 1997-05-02
JPH10502656A (en) 1998-03-10
WO1996002240A3 (en) 1997-02-13
WO1996002240A2 (en) 1996-02-01

Similar Documents

Publication Publication Date Title
GB2285582B (en) Medical clip
EP0699419A3 (en) Osteosynthetic fixateur
EP0785806A4 (en) Single use syringe
GB9425493D0 (en) Modified cannula
GB9414157D0 (en) Medical use
HUP9901448A3 (en) Novel medical use
GB9408084D0 (en) Medical treatment
EP0797592A4 (en) Human stanniocalcin-alpha
ZA947865B (en) Human glactokinase
GB9617550D0 (en) Medical ice-pack
GB9601042D0 (en) Medical use
GB2290706B (en) Medical device
EP0795006A4 (en) HUMAN MutT2
GB2310804B (en) Modified cannula
GB9606686D0 (en) Medical use
GB9626920D0 (en) Medical use
GB9513275D0 (en) Patient support
GB9418077D0 (en) Medical aid
GB9405084D0 (en) Medical devices
HU9502355D0 (en) Human interleukin-6-inhibitor
ZA949714B (en) Human MutT2
GB9416297D0 (en) Disposable scoopsack
GB9425773D0 (en) Medical treatment
GB9424728D0 (en) Medical treatment
GB9403306D0 (en) Medical treatment